On September 13, 2024, Charles McLaughlin, Senior Vice President - Chief Financial Officer of Fortive Corp (FTV, Financial), sold 6,864 shares of the company. Following this transaction, the insider now owns 73,391 shares of Fortive Corp. The sale was documented in a recent SEC Filing.
Fortive Corp is a diversified industrial technology conglomerate that designs, develops, manufactures, and markets professional and engineered products, software, and services for a variety of end markets.
Over the past year, Charles McLaughlin has sold a total of 47,701 shares of Fortive Corp and has not purchased any shares. This recent transaction is part of a broader trend seen within the company, where there have been 8 insider sells and no insider buys over the past year.
On the day of the sale, shares of Fortive Corp were trading at $74.03. This pricing gives the company a market cap of approximately $25.83 billion. The price-earnings ratio of the stock stands at 29.61, which is above both the industry median of 21.04 and the historical median for the company.
According to the GF Value, an intrinsic value estimate used by GuruFocus, Fortive Corp has a price-to-GF-Value ratio of 0.98, indicating that the stock is Fairly Valued. The GF Value is calculated based on historical trading multiples, an adjustment factor from GuruFocus, and future business performance estimates from analysts.
This insider sale might interest investors tracking insider behaviors as an indicator of corporate confidence and potential future stock performance.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
